
Decoding 5q14.3 Microdeletion Syndrome: Genetic Testing as a Beacon of Hope
Unlock insights into 5q14.3 microdeletion syndrome. Explore genetic testing's role in diagnosis, personalized treatments, and informed family planning.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Unlock insights into 5q14.3 microdeletion syndrome. Explore genetic testing's role in diagnosis, personalized treatments, and informed family planning.

Explore how genetic testing aids in diagnosing Alagille syndrome, a complex genetic disorder affecting the liver, heart, and more; vital for timely intervention.

Unlock the potential of genetic testing in diagnosing aldosterone-producing adrenal cortex adenoma, offering early diagnosis, personalized treatment, and familial screening.

Explore alpha-N-acetylgalactosaminidase deficiency, its symptoms, and how genetic testing aids in diagnosis, early intervention, and personalized treatment plans.

Unlock personalized treatment for anaplastic ependymoma with genetic testing. Explore targeted therapies and improve outcomes for this aggressive brain tumor.

Explore how genetic testing, like FISH and NGS, identifies 1p/19q co-deletion in anaplastic oligodendroglioma, guiding personalized treatment strategies.

Explore how genetic testing unveils angiosarcoma's genetic landscape, aiding early detection, targeted therapies, and improved outcomes in this aggressive cancer.

Explore the impact of genetic testing on AP4-related intellectual disability and spastic paraplegia, aiding in diagnosis, personalized care, and family planning.